HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Clearbridge Investments LLC

Clearbridge Investments LLC reduced its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 13.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,060,026 shares of the company's stock after selling 328,366 shares during the quarter. Clearbridge Investments LLC owned about 2.38% of HealthEquity worth $197,659,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the stock. Wealthfront Advisers LLC purchased a new stake in HealthEquity during the 4th quarter valued at about $10,304,089,000. Vanguard Group Inc. lifted its holdings in shares of HealthEquity by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company's stock worth $861,256,000 after purchasing an additional 99,624 shares during the period. State Street Corp boosted its position in HealthEquity by 0.8% in the third quarter. State Street Corp now owns 3,131,900 shares of the company's stock valued at $256,346,000 after buying an additional 23,613 shares during the last quarter. Geode Capital Management LLC raised its position in HealthEquity by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company's stock worth $170,197,000 after buying an additional 15,145 shares during the last quarter. Finally, Franklin Resources Inc. boosted its holdings in shares of HealthEquity by 0.7% in the 3rd quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company's stock valued at $139,369,000 after acquiring an additional 11,659 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

HealthEquity Price Performance

Shares of HealthEquity stock traded down $4.17 during mid-day trading on Friday, reaching $78.80. 1,933,052 shares of the stock traded hands, compared to its average volume of 740,684. The stock has a market capitalization of $6.82 billion, a PE ratio of 72.29, a PEG ratio of 1.60 and a beta of 0.49. The business has a 50-day moving average of $101.66 and a 200 day moving average of $96.21. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares of the company's stock, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.20% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on HQY shares. Wells Fargo & Company boosted their price objective on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. KeyCorp lowered their price objective on HealthEquity from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Monday, March 24th. Royal Bank of Canada raised their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a research note on Tuesday, December 10th. Barrington Research reissued an "outperform" rating and set a $112.00 price target on shares of HealthEquity in a report on Friday, March 14th. Finally, Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their price target for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Buy" and an average price target of $112.58.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.